https://www.selleckchem.com/pr....oducts/PHA-739358(Da
8%) were enrolled; 34 (57%) were ablated in RVOT septum and 26 (43%) patients in the RVOT free wall area. Propensity match with 60 non-AI-guided patients was performed. Acute outcomes and complications resulted comparable. At 6 months, arrhythmic recurrence was more common in non-AI-guided patients whether in general (28% vs. 7% P = 0.003) or by ablated area (RVOT free wall 27% vs. 4%, P = 0.06; RVOT septum 29% vs. #link# 9% P = 0.05). Ablation Index guidance was associated with improved survival from arrhythmic recurrenc
Like
Comment
Share
